STI - Stirling Products

Hi folks,

STI ....."Signs Agreement with South African Group - AFGRI Operations"

Looks like STI has found good support, with today's
announcement ..... albeit a couple of days later
than expected (see post below) ...

Next, a run up to the next targeted date for a pullback,
around 9-13122005 ..... ???

-----

Previous alert posted,

Wednesday 30/11/05 09:20am on SS forum:



Hi folks,

STI ..... almost primed for another move up ...

Key dates ahead may be:

01-02122005 ..... positive spotlight on STI ... breakout?

09-13122005 ..... significant and negative move??

21122005 ..... significant and positive news.

22-27122005 ..... negative move???

02-13012006 ..... flat-to-down period???

30012006 ..... negative news about technology???

14022006 ..... significant news product/technology
changes???

28022006 ..... more about changes???

happy days

yogi

Hi folks,

STI ..... looks like yesterday's doji has
been confirmed as a signal low .....

Will be looking for some positive news,
around 30032006, just ahead of two major
time cycles, on 03042006 ..... after that,
STI should be in slow-recovery mode, as
it lifts off round-bottom lows.

Longer-term ..... outlook for STI looks good
for some big news, in January 2007.

happy days

yogi

STI continues to plug away making more positive announcements about its growth promoters. When it gets to manufacturing, it will steal a huge share of a massive global market. This is definitely one to throw 5-10k and forget about for about 12 months and it could be up to 30c based on my calculations from its current lows of 6ish.

Just my opinion.

Cheers

STI - Stirling in deal with major

Merial is second biggest vet medicine company and STI has made a deal. Will the stock go up, or will it go down?

ANN.

ABN 32 077 105 429
Level 11, BGC Centre, 28 The Esplanade, Perth WA 6000
27 AUGUST, 2007
STIRLING STARTS REVENUE STREAM IN NORTH AMERICA
• Immediate revenues to be generated through Stirling Products North
America Inc.
• Focused scale-up as Stirling expands new business phase.

Stirling Products Limited (ASX:STI) advises shareholders that it will immediately
commence generating revenues through the newly formed North America subsidiary
Stirling Product North America Inc.
Following the recent approval by Stirling shareholders on August 22 (ASX: August 22,
2007), final transactions for the completion of the acquisition were held at the Canadian
Consulate in Sydney on Friday August 24. The signing of the Share Sale and Purchase
agreements was attended by the Canadian Consul General, Deputy Consul General and
other members of the Canadian Trade Commission.
“This is a great outcome. It provides revenue, cash flow and a tangible, approved
product to grow market share and brand awareness. The other great benefit is that it
provides a sales and distribution pathway to market for our new and innovative Rsalbutamol
products,” said Stirling Products Limited CEO Dr Calvin London.
Stirling Products North America Inc. (which will continue to trade as Progressive
BioActives Incorporated, PBI) has acquired technology to extract and produce natural
bioactive ingredients for immune health & productivity solution for the agriculture,
aquaculture and pet feed industries. Stirling will tap into the US$15 billion animal feed
additives market with PBI’s existing beta glucan product, ProVale™ as well as Stirling’s
own growth promoters which are under development.

At the Board meeting of Stirling Products late last week, approval was given for the first
stage of expansion to the Prince Edward Island facility, which will double the company’s
output and a cost of less than CAD$100K.
“This deal is all about synergy allowing us to combine our respective technologies for
mutual benefit and global growth in all markets especially the Americas, with a range of
complementary animal health products,” said Dr London. “Stirling will ensure that we
are in a position to supply product to customers before they sign distribution agreements
with us. As we have just signed some new agreements (ASX July 30, 2007), we now
need to go to the next stage of production,” he added.

Australian Stock Reports has published STI as a buy at 5 cents on 23 May report. It says that to buy this upto 6 cents and predicted 15 cents in 12 months

Any one else to provide some research on the contrary or similar direction ?

Miner said:

Australian Stock Reports has published STI as a buy at 5 cents on 23 May report. It says that to buy this upto 6 cents and predicted 15 cents in 12 months

Click to expand...

Well, it's almost 12 months further on, and we've just seen STI rocket in one day from 0.017 to 0.038, so I suppose there's another month to go till we see that 0.15 ... :

Stirling's has just announced that a product from it's recent joint venture partner is a "Breakthrough in Extensively Drug-Resistant Tuberculosis", see ASX announcement -
http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=00944559

My sincere best wishes to all concerned, and pardon my envious cynicism, but I allow myself to wonder that maybe this news is so good, it's too good.

Disclosure: do not hold, have not held. Will watch carefully in case I choose to hold.

STI major announcement of independent review of strategy

http://newsstore.theage.com.au/apps/previewDocument.ac?docID=GCA00954387STI

Other recent news, includes a break through in AIDs treatment

http://newsstore.theage.com.au/apps/previewDocument.ac?docID=GCA00954387STI

Chart shows recovery and support at .2 resistance .4, renewed interest in this stock is from J.V. being a salvation for the company and break throughs in treatments.



If recent news releases for this stock are an indication of how this stock will respond tomorrow it should be a positive move

High Risk but potential for high returns, trade at your own risk

Back in the April this stock had an intra day high of 8c IIRC. I have watched it ever since.

It's had a steady rise for a few weeks now and buy orders seem to be accumulating. Today i saw the number of bidders out do the sellers. Previously the sellers have been in favour by 39-40. Seems like something is up?

I've regularly checked these forums in case someone had created an STI thread before, but i can't find any. It seems strange for a company with such large plans in 2010 to not have some sort of thread either singing it's praises or deriding it.

So do people know of it and if so, what are your opinions?

Even the briefest of an outline on what they do and there size and profitability would be nice...ok so they have large plans, well what are these plans? what do you think of these plans? :dunno: are these plans doable, realistic? anything.

I've been watching STI for about a year now. If you've been watching them for that long, I'm sure you've seen their ups and downs, often for no particular reason. Often as you've seen, the ups are on the back of hot air announcements, with resulting downs greater than the ups. Some analysts see it likely that they won't be an ongoing concern for too long, and I tend to think they're likely right.

STI does have its peaks though, so if you want to jump in and take a risk, go for it Just be ready to get burned

Pharmaceuticals, Market Cap 12,113,208, First traded 18 July 1997

Here is a recent investor presentation http://www.asx.com.au/asxpdf/20091204/pdf/31mjxpz3mbgysg.pdf

At a quick glance actually don't look to bad with low debt, some cash and some good products going forward.

So_Cynical said:

Pharmaceuticals.....
At a quick glance actually don't look to bad with low debt, some cash and some good products going forward.

Click to expand...

Started life as a livestock & veterinary drug developer, and earlier this year they announced spectacular results for a human drug for treating patients co-infected with AIDS and tuberculosis (a major cause of death for AIDS sufferers, especially in regions with a poor health infrastructure, Africa particularly).

I was watching it for a while, but I couldn't help thinking the news was too good, but maybe that's just me.

Purple XS2 said:

Started life as a livestock & veterinary drug developer, and earlier this year they announced spectacular results for a human drug for treating patients co-infected with AIDS and tuberculosis (a major cause of death for AIDS sufferers, especially in regions with a poor health infrastructure, Africa particularly).

I was watching it for a while, but I couldn't help thinking the news was too good, but maybe that's just me.

Click to expand...

They also claimed to have a miracle fat loss drug (for humans), among other things (like swine flu treatments), some close to being ready for market, but gee, suddenly they flipped around and went back to making basic food additives for livestock, completely ignoring their large suite of incredibly lucrative miracle human drugs, which they had been claiming had 'blockbuster potential'. It's a bit difficult to have any faith in their integrity when they repeatedly make incredible claims and these projects just amount to nothing at all. If you sit down and read the last 12 months of their announcements, I doubt you'll want to put your money on the table, but having said that, many people will be thinking the same, and perhaps they have become so undervalued that the current SP represents a bargain in respect to whatever amount of legitimate business they are actually carrying out (if any!).

So_Cynical said:

Even the briefest of an outline on what they do and there size and profitability would be nice...ok so they have large plans, well what are these plans? what do you think of these plans? :dunno: are these plans doable, realistic? anything.

Click to expand...

Well my question was directed at those who had knew of the stock, but people who don't. But to help you out, i'll provide you some detail.

They're a pharmaceutical company that holds patents for drugs and drug delivery mechanisms. They specialise in human as well as animal health.

Most recent developments include:
Stirling Products to launch generic pharma brand in Australia http://imagesignal.comsec.com.au/asxdata/20091223/pdf/01025589.pdf

Publication of breakthrough study shows Immunoxel to have high rate cure of TB patients co-infected with HIV who received the immumodulator ImmunoXel prior to treatment. http://imagesignal.comsec.com.au/asxdata/20090720/pdf/00969720.pdf

Stirling products to be launched in the US http://imagesignal.comsec.com.au/asxdata/20090803/pdf/00974536.pdf

Signed agreement with Innovative Biotech of Keffi, Nigeria & Maryland USA to register, trial and market Dzherelo (ImmunoXel). http://imagesignal.comsec.com.au/asxdata/20091118/pdf/01012221.pdf

South Africa grants proval patent http://imagesignal.comsec.com.au/asxdata/20091020/pdf/01000131.pdf

LOIs for distribution of Stirling Products botanic range through out SA http://imagesignal.comsec.com.au/asxdata/20090805/pdf/00975035.pdf

Targets for 2010:
Breakeven mid 2010
Annualised sales revenue of $30m by end 2010

Products In Process of being launched:
* ImmunoXel - for all strains of TB, TB/HIV co-infection and AIDS. Contains extracts regarded as beneficial for immunity
* Cholonorm - Contains extracts regarded as beneficial for Cholesterol health
* Diabetin - contains botanical extract known to lower blood sugar
* Allergon - for all allergies
* Povale - patented beta glucan feed additive that promotes health and resistance to disease as well as growth production in production animals

http://imagesignal.comsec.com.au/asxdata/20091021/pdf/01000988.pdf


P.S STI was up $0.003 to $0.017 today with volume 18+ million

Being traded quite a lot still.

Wednesday topped 180000000 shares traded and ended trade down 0.2c from the previous days close of 1.7.

Thursday finished trade up 0.3c to 1.8c with volume exceeding 14000000. Number of buys and volume out numbering the sales and it's volume by 18 and 30000000 respectively.

Interesting stock pods and quite a few announcements since Jan 2010. I hold but am surprised that the movement has been curtailed by possibly someone taking a position. Guess the Director should have a look at the shareholder list decide for themselves.

Cheers

Have made a few announcements and doing some acquisitions makes STI a little more interesting. Certainly a bit of a turnaround since last year.

http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01112379

Stirling has its AGM at 11.30am at The Grill, Sydney today.

Should be interesting to see the working prototype of the HDA device and possibly some interesting announcements seeing the media has been invited.

Great news came up for STI, if they have successfully secured the 6m funding, the share price would fly again